EUCTR2005-001260-31-IT进行中（未招募）不适用
PHASE II MULTICENTRIC STUDY OF SEQUENTIAL CHEMOTHERAPY WITH GEMCITABINE FOLLOWED FROM DOCETAXEL IN ELDERLY PATIENTS WITH NOT SMALL CELLS LUNG CANCER NSCLC ADVANCED - POLTO-Elderly04
AZIENDA USL 6 LIVORNO ZONA LIVORNESE0 个研究点目标入组 60 人开始时间: 2006年3月13日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •pulmonary histologic or cytological Diagnosis of NSLC measurable Disease second criteria RECIST Stage IIIB for cytologically positive pleuric deposit or sopraclavearic metastases Stage IV Age 70 years ECOG performance status 0 - 2 Expected life 3 months Adapted medullary functionality leucociti 4,0 x109/L, neutrophil 2,0 x 109/L, 100 plt x 109/L, emoglobina 10 g/dL Adapted renal hepatic functionality and bilirubinemia 1,2 mg/dL, transaminases 2,5 x VN, creatininemia 1,5 mg/dL informed Consent written
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Diagnosi the brought back criteria inel protocol of other malignant neoplasie in last the 5 years except the carcinoma in situ of the cervix uterina and the basalioma or ca. to spinocellulare cutaneous adequately deals Previous chemotherapy to you for the metastatic disease Radioterapy on the neoplastic lesions cerebral Metastase sintomatic scompensate metabolic Diseases or infections in action cardiac Aritmye or ischemic cardiopathy not controlled impossibility to execute an adequate one follow-up
研究者
相似试验
进行中（未招募）
不适用
Multicenter Phase II study of Sequential Chemotherapy with Cisplatin/Gemcitabine Followed by Docetaxel in Elderly Advanced Non-Small-Cell Lung Cancer (NSCLC) patients - ELDERLY-NEXTEUCTR2008-005294-35-ITAZIENDA USL 6 LIVORNO ZONA LIVORNESE
进行中（未招募）
不适用
Multizentrische Phase II Studie: Induktionschemotherapie und Chemoradiotherapie jeweils in Kombination mit Cetuximab bei Patienten mit nicht-metastasiertem Ösophaguskarzinomnbehandeltes, histologisch gesichertes, nicht-metastasiertes Ösophaguskarzinom (Plattenepithelkarzinom)MedDRA version: 9.1Level: LLTClassification code 10056104Term: Squamous cell carcinoma of oesophagusEUCTR2008-001016-21-ATArbeitsgemeinschaft medikamentöse Tumortherapie gemeinnützige GmbH
尚未招募
2 期
A Randomized Phase II Study of Systemic Chemotherapy with or without HAI FUDR/Dexamethasone in Patients with Unresectable Intrahepatic CholangiocarcinomaNL-OMON56819Memorial Sloan Kettering Cancer Center60
尚未招募
3 期
Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical HysterectomyCTRI/2019/04/018382RG National Research Group Oncology
招募中
2 期
A randomized phase II study of systemic chemotherapy with and without trastuzumab followed by surgery in HER2 positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis (JCOG1301C:Trigger Study)HER2 positive gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis.JPRN-UMIN000016920Japan Clinical Oncology Group (JCOG)130